💨 COPD Acute Exacerbation (AECOPD) Management
This tool applies the Anthonisen cardinal symptoms and ventilation needs to judge the antibiotic indication in AECOPD and frames steroid, bronchodilator, oxygen, and ventilation therapy.
Sputum purulence is the pivotal cardinal symptom — two symptoms only trigger antibiotics when purulence is one of them. (original synthesis · not guideline verbatim)
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Use to decide whether antibiotics are indicated and to set the steroid course, controlled-oxygen target, and noninvasive ventilation threshold.
How it works
Antibiotics if all three cardinal symptoms, two including purulence, or ventilation needed. Prednisolone 40 mg/d × 5 days; SABA ± SAMA; oxygen SpO₂ 88–92%; NIV at pH < 7.35 or severe dyspnea.
Key points
- Sputum purulence is the pivotal cardinal symptom — two symptoms only trigger antibiotics when purulence is one of them. (original synthesis · not guideline verbatim)
- Controlled oxygen targets SpO₂ 88–92% to avoid CO₂ retention in chronic hypercapnia.
- Pseudomonas risk factors shift empiric therapy to an anti-pseudomonal regimen with cultures.
References
- Global Initiative for Chronic Obstructive Lung Disease. GOLD Report 2024.
- Anthonisen NR, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Worsening dyspnea | Present |
|---|---|
| Increased sputum volume | Present |
| Sputum purulence | Present |
| Needs invasive or noninvasive ventilation | Yes |
| Arterial pH (optional) | 7.30 |
| Pseudomonas aeruginosa risk factors | Present |
→AntibioticsIndicated, recommend use
- Antibiotic indication (Anthonisen)：Cardinal symptoms 3/3: met (all three / two including purulence / ventilation needed)
- Antibiotic regimen：Pseudomonas risk factors: ciprofloxacin, or an anti-pseudomonal β-lactam ± aminoglycoside
- Systemic steroid：Prednisolone 40 mg/d × 5 days (or nebulized budesonide 8 mg/d as an alternative)
| Worsening dyspnea | Absent |
|---|---|
| Increased sputum volume | Absent |
| Sputum purulence | Absent |
| Needs invasive or noninvasive ventilation | No |
| Arterial pH (optional) | 7.30 |
| Pseudomonas aeruginosa risk factors | Absent |
→AntibioticsNot recommended for now
- Antibiotic indication (Anthonisen)：Cardinal symptoms 0/3: not met
- Antibiotic regimen：Antibiotics not recommended for now (only 1 symptom, or 2 without purulence and no ventilation need)
- Systemic steroid：Prednisolone 40 mg/d × 5 days (or nebulized budesonide 8 mg/d as an alternative)
Frequently asked questions
- What is COPD Acute Exacerbation (AECOPD) Management?
- This tool applies the Anthonisen cardinal symptoms and ventilation needs to judge the antibiotic indication in AECOPD and frames steroid, bronchodilator, oxygen, and ventilation therapy.
- How is COPD Acute Exacerbation (AECOPD) Management calculated? What is the core formula?
- Antibiotics if all three cardinal symptoms, two including purulence, or ventilation needed. Prednisolone 40 mg/d × 5 days; SABA ± SAMA; oxygen SpO₂ 88–92%; NIV at pH < 7.35 or severe dyspnea.
- When is COPD Acute Exacerbation (AECOPD) Management used?
- Use to decide whether antibiotics are indicated and to set the steroid course, controlled-oxygen target, and noninvasive ventilation threshold.
- What are the key clinical points for COPD Acute Exacerbation (AECOPD) Management?
- Sputum purulence is the pivotal cardinal symptom — two symptoms only trigger antibiotics when purulence is one of them. (original synthesis · not guideline verbatim) Controlled oxygen targets SpO₂ 88–92% to avoid CO₂ retention in chronic hypercapnia. Pseudomonas risk factors shift empiric therapy to an anti-pseudomonal regimen with cultures.
- What are the limits and cautions when using COPD Acute Exacerbation (AECOPD) Management?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is COPD Acute Exacerbation (AECOPD) Management calculated in practice? Can you show a worked example?
- Inputs: Worsening dyspnea Present, Increased sputum volume Present, Sputum purulence Present, Needs invasive or noninvasive ventilation Yes, Arterial pH (optional) 7.30, Pseudomonas aeruginosa risk factors Present → Result: Antibiotics Indicated, recommend use（Antibiotic indication (Anthonisen): Cardinal symptoms 3/3: met (all three / two including purulence / ventilation needed), Antibiotic regimen: Pseudomonas risk factors: ciprofloxacin, or an anti-pseudomonal β-lactam ± aminoglycoside, Systemic steroid: Prednisolone 40 mg/d × 5 days (or nebulized budesonide 8 mg/d as an alternative)） Inputs: Worsening dyspnea Absent, Increased sputum volume Absent, Sputum purulence Absent, Needs invasive or noninvasive ventilation No, Arterial pH (optional) 7.30, Pseudomonas aeruginosa risk factors Absent → Result: Antibiotics Not recommended for now（Antibiotic indication (Anthonisen): Cardinal symptoms 0/3: not met, Antibiotic regimen: Antibiotics not recommended for now (only 1 symptom, or 2 without purulence and no ventilation need), Systemic steroid: Prednisolone 40 mg/d × 5 days (or nebulized budesonide 8 mg/d as an alternative)）